Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Treatment Options in Cardiovascular Medicine
Published in: Current Treatment Options in Cardiovascular Medicine 4/2015

01-04-2015 | Arrhythmia (D Spragg, Section Editor)

Atrial Fibrillation Ablation in the Era of Cryoballoon and Force-Sensing Catheters: Freeze or Burn?

Authors: Shaun Bhatty, MD, Anastasios P. Saliaris, MD

Published in: Current Treatment Options in Cardiovascular Medicine | Issue 4/2015

Login to get access

Opinion statement

Atrial fibrillation can adversely affect the quality of life for many patients. Though antiarrhythmic drug therapy remains an option for the treatment of atrial fibrillation, the drugs are associated with numerous side effects. Atrial fibrillation ablation has been shown to be as efficacious as antiarrhythmic drug therapy. The field of atrial fibrillation ablations has evolved over time from utilizing radiofrequency energy to using cryoenergy. Newer technologies are being developed with efforts to improve outcomes in patients undergoing atrial fibrillation ablations. This article will highlight two such technologies: cryoballoon ablation catheters and contact force-sensing catheters. These novel catheters appear to be further revolutionizing this young field in electrophysiology.
Literature
1.
Haïssaguerre M, Jaïs P, Shah D, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659–66.CrossRefPubMed
2.
Benjamin E, Wolf P, D’Agostino R, Silbershatz H, Kannel W, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946–52.CrossRefPubMed
3.
Boriani G, Valzania C, Biffi M, Diemberger I, Ziacchi M, Martignani C. Asymptomatic Lone Atrial Fibrillation - how can we Detect the Arrhythmia? Curr Pharm Des. 2014.
4.
Naccarelli G, Wolbrette D, Khan M, et al. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am J Cardiol. 2003;91(6A):15D–26D.CrossRefPubMed
5.
Wazni O, Marrouche N, Martin D, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005;293(21):2634–40.CrossRefPubMed
6.••
Morillo C, Verma A, Connolly S. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014;311(7):692–700. Radiofrequency ablation has a lower rate of recurrent atrial arrhythmias at 2 years compared to antiarrhythmic drug therapy.
7.
Cosedis Nielsen JJA, Raatikainen P. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med. 2012;367(17):1587–95.CrossRefPubMed
8.
Pappone C, Oreto G, Rosanio S, et al. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation. 2001;104(21):2539–44.CrossRefPubMed
9.
Cappato R, Calkins H, Chen S, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32–8.CrossRefPubMed
10.••
January C, Wann L, Alpert J, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: Executive summary. Journal of the American College of Cardiology. 2014. Guidelines for the management of atrial fibrillation.
11.
Scheinman M, Morady F, Hess D, Gonzalez R. Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. JAMA. 1982;248(7):851–5.CrossRefPubMed
12.
13.
Fisher J, Brodman R, Kim S, et al. Attempted nonsurgical electrical ablation of accessory pathways via the coronary sinus in the Wolff-Parkinson-White syndrome. J Am Coll Cardiol. 1984;4(4):685–94.CrossRefPubMed
14.
15.
Borggrefe M, Budde T, Podczeck A, Breithardt G. High frequency alternating current ablation of an accessory pathway in humans. J Am Coll Cardiol. 1987;10(3):576–82.CrossRefPubMed
16.
Haïssaguerre M, Gencel L, Fischer B, et al. Successful catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 1994;5(12):1045–52.CrossRefPubMed
17.
Calkins H, Reynolds M, Spector P, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol. 2009;2(4):349–61.CrossRefPubMed
18.
Dagres N, Hindricks G, Kottkamp H, et al. Complications of atrial fibrillation ablation in a high-volume center in 1,000 procedures: still cause for concern? J Cardiovasc Electrophysiol. 2009;20(9):1014–9.CrossRefPubMed
19.
Zhou L, Keane D, Reed G, Ruskin J. Thromboembolic complications of cardiac radiofrequency catheter ablation: a review of the reported incidence, pathogenesis and current research directions. J Cardiovasc Electrophysiol. 1999;10(4):611–20.CrossRefPubMed
20.
Andrade J, Khairy P, Guerra P, et al. Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies. Heart Rhythm. 2011;8(9):1444–51.CrossRefPubMed
21.
Haines D, Watson D. Tissue heating during radiofrequency catheter ablation: a thermodynamic model and observations in isolated perfused and superfused canine right ventricular free wall. Pacing Clin Electrophysiol. 1989;12(6):962–76.CrossRefPubMed
22.
Haines D, Verow A. Observations on electrode-tissue interface temperature and effect on electrical impedance during radiofrequency ablation of ventricular myocardium. Circulation. 1990;82(3):1034–8.CrossRefPubMed
23.
Khairy P, Chauvet P, Lehmann J, et al. Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation. 2003;107(15):2045–50.CrossRefPubMed
24.
Calkins H, Prystowsky E, Carlson M, Klein L, Saul J, Gillette P. Temperature monitoring during radiofrequency catheter ablation procedures using closed loop control. Atakr Multicenter Investigators Group. Circulation. 1994;90(3):1279–86.CrossRefPubMed
25.
Gallagher J, Sealy W, Anderson R, et al. Cryosurgical ablation of accessory atrioventricular connections: a method for correction of the pre-excitation syndrome. Circulation. 1977;55(3):471–9.CrossRefPubMed
26.
Camm J, Ward D, Spurrell R, Rees G. Cryothermal mapping and cryoablation in the treatment of refractory cardiac arrhythmias. Circulation. 1980;62(1):67–74.CrossRefPubMed
27.
Gillette P, Swindle M, Thompson R, Case C. Transvenous cryoablation of the bundle of his. Pacing Clin Electrophysiol. 1991;14(4):504–10.CrossRefPubMed
28.
Rodriguez L, Leunissen J, Hoekstra A, et al. Transvenous cold mapping and cryoablation of the AV node in dogs: observations of chronic lesions and comparison to those obtained using radiofrequency ablation. J Cardiovasc Electrophysiol. 1998;9(10):1055–61.CrossRefPubMed
29.
Kojodjojo P, Wyn DD. How to perform antral pulmonary venous isolation using the cryoballoon. Heart Rhythm. 2011;8(9):1452–6.CrossRefPubMed
30.
Kojodjojo P, O’Neill M, Lim P, et al. Pulmonary venous isolation by antral ablation with a large cryoballoon for treatment of paroxysmal and persistent atrial fibrillation: medium-term outcomes and non-randomized comparison with pulmonary venous isolation by radiofrequency ablation. Heart. 2010;96(17):1379–84.CrossRefPubMedCentralPubMed
31.
Klein G, Gardiwal A, Oswald H. Catheter-based cryoablation of atrial fibrillation: state of the art. Minerva Cardioangiol. 2008;56(6):623–33.PubMed
32.••
DeVille J, Svinarich J, Dan D. Comparison of resource utilization of pulmonary vein isolation: cryoablation versus RF ablation with three-dimensional mapping in the value PVI study. J Invasive Cardiol. 2014;26(6):268–72. A comparison of cryoballoon ablation versus radiofrequency ablation.PubMed
33.
Sarabanda A, Bunch T, Johnson S, et al. Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system. J Am Coll Cardiol. 2005;45(10):1902–12.CrossRef
34.••
Packer D, Kowal R, Wheelan K. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American arctic front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713–23. Study that showed that cryoballoon ablation is safe and effective for the treatment of patients with symptomatic paroxysmal atrial fibrillation.CrossRefPubMed
35.
Bordignon S, Fürnkranz A, Schmidt B, Chun K. Remaining ice cap on second-generation cryoballoon after deflation. Circ Arrhythm Electrophysiol. 2012;5(5).
36.
Linhart M, Bellmann B, Mittmann-Braun E, et al. Comparison of cryoballoon and radiofrequency ablation of pulmonary veins in 40 patients with paroxysmal atrial fibrillation: a case–control study. J Cardiovasc Electrophysiol. 2009;20(12):1343–8.CrossRefPubMed
37.••
Xu J, Huang Y, Cai H, et al. Is cryoballoon ablation preferable to radiofrequency ablation for treatment of atrial fibrillation by pulmonary vein isolation? A meta-analysis.. PLoS One. 2014;9(2). Another comparison of cryoballoon ablation versus radiofrequency ablation.
38.
Mandell J, Amico F, Parekh S, Snow J, Germano J, Cohen T. Early experience with the cryoablation balloon procedure for the treatment of atrial fibrillation by an experienced radiofrequency catheter ablation center. J Invasive Cardiol. 2013;25(6):288–92.PubMed
39.
Luik A, Merkel M, Hoeren D, Riexinger T, Kieser M, Schmitt C. Rationale and design of the FreezeAF trial: a randomized controlled noninferiority trial comparing isolation of the pulmonary veins with the cryoballoon catheter versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation. Am Heart J. 2010;159(4):555–60.CrossRefPubMed
40.••
Fürnkranz A, Brugada J, Albenque J, et al. Rationale and design of FIRE AND ICE: A multicenter randomized trial comparing efficacy and safety of pulmonary vein isolation using a cryoballoon versus radiofrequency ablation with 3D-reconstruction. J Cardiovasc Electrophysiol. 2014. Future study that will further compare cryoballoon ablation with radiofrequency ablation for the treatment of paroxysmal atrial fibrillation.
41.••
Andrade J, Monir G, Pollak S, et al. Pulmonary vein isolation using “contact force” ablation: The effect on dormant conduction and long-term freedom from recurrent atrial fibrillation-A prospective study. Heart Rhythm. 2014. This study illustrates the importance of contact force during atrial fibrillation ablations.
42.
Verma A, Kilicaslan F, Pisano E, et al. Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction. Circulation. 2005;112(5):627–35.CrossRefPubMed
43.
Matsuo S, Yamane T, Date T, et al. Reduction of AF recurrence after pulmonary vein isolation by eliminating ATP-induced transient venous re-conduction. J Cardiovasc Electrophysiol. 2007;18(7):704–8.CrossRefPubMed
44.
Yokoyama K, Nakagawa H, Shah D, et al. Novel contact force sensor incorporated in irrigated radiofrequency ablation catheter predicts lesion size and incidence of steam pop and thrombus. Circ Arrhythm Electrophysiol. 2008;1(5):354–62.CrossRefPubMed
45.••
Kuck K, Reddy V, Schmidt B. A novel radiofrequency ablation catheter using contact force sensing: Toccata study. Heart Rhythm. 2012;9(1):18–23. A study showing the safety and efficacy of a contact force sensing catheter.CrossRefPubMed
46.
Burkhardt J, Natale A. New technologies in atrial fibrillation ablation. Circulation. 2009;120(15):1533–41.CrossRefPubMed
47.
Okumura Y, Johnson S, Bunch T, Henz B, O’Brien C, Packer D. A systematical analysis of in vivo contact forces on virtual catheter tip/tissue surface contact during cardiac mapping and intervention. J Cardiovasc Electrophysiol. 2008;19(6):632–40.CrossRefPubMed
48.••
Stabile G, Solimene F, Calò L. Catheter-tissue contact force for pulmonary veins isolation: a pilot multicentre study on effect on procedure and fluoroscopy time. Europace. 2014;16(3):335–40. A study showing improved procedural and fluoroscopy times when a contact force sensing catheter is used.CrossRefPubMedCentralPubMed
49.
Reddy V, Shah D, Kautzner J, et al. The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm. 2012;9(11):1789–95.CrossRefPubMed
50.••
Natale A, Reddy V, Monir G. Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. J Am Coll Cardiol. 2014;64(7):647–56. This study illustrates the safety and efficacy of another novel force sensing catheter.CrossRefPubMed
51.
Providência R, Marijon E, Combes S, et al. Higher contact-force values associated with better mid-term outcome of paroxysmal atrial fibrillation ablation using the SmartTouch™ catheter. Europace. 2014.
52.
Marijon E, Fazaa S, Narayanan K, et al. Real-time contact force sensing for pulmonary vein isolation in the setting of paroxysmal atrial fibrillation: Procedural and 1-year results. J Cardiovasc Electrophysiol. 2013.
53.••
Jourda F, Providencia R, Marijon E, et al. Contact-force guided radiofrequency vs. second-generation balloon cryotherapy for pulmonary vein isolation in patients with paroxysmal atrial fibrillation-a prospective evaluation. Europace. 2014. A comparison of a contact force-sensing catheter with a cryoballoon ablation catheter.
Metadata
Title
Atrial Fibrillation Ablation in the Era of Cryoballoon and Force-Sensing Catheters: Freeze or Burn?
Authors
Shaun Bhatty, MD
Anastasios P. Saliaris, MD
Publication date
01-04-2015
Publisher
Springer US
Published in
Current Treatment Options in Cardiovascular Medicine / Issue 4/2015
Print ISSN: 1092-8464
Electronic ISSN: 1534-3189
DOI
https://doi.org/10.1007/s11936-015-0374-1

Other articles of this Issue 4/2015

Current Treatment Options in Cardiovascular Medicine 4/2015 Go to the issue

Arrhythmia (D Spragg, Section Editor)

Honing in on Optimal Ventricular Pacing Sites: an Argument for His Bundle Pacing

Arrhythmia (D Spragg, Section Editor)

Diagnosis and Ablation of Long RP Supraventricular Tachycardias

Arrhythmia (D Spragg, Section Editor)

Mechanisms Underlying AF: Triggers, Rotors, Other?

Cerebrovascular Disease and Stroke (N Rost, Section Editor)

Intravenous Thrombolysis for Acute Stroke: Current Standards and Future Directions

Coronary Artery Disease (D Feldman and V Voudris, Section Editors)

Statins in the Prevention of Contrast-Induced Nephropathy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits